This clinical-stage biotech advancing precision medicines reported a notable insider sale amid strong one-year share ...
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision ...
Maze Therapeutics is a U.S. biotech advancing clinical-stage precision medicines for renal and metabolic diseases.
1mon
Maze Therapeutics CSBO Sells 7,500 Shares for $190,000 After Strong Trial Results and Q4 Financials
This clinical-stage biotech focused on precision medicines for renal and metabolic diseases just reported a notable insider sale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results